Activity-Regulated Cytoskeleton-Associated Protein (Arc) (Middle Region) Peptide
-
- Target See all Arc products
- Arc (Activity-Regulated Cytoskeleton-Associated Protein (Arc))
- Protein Region
- Middle Region
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- TIANLERWVK REMHVWREVF YRLERWADRL ESMGGKYPVG SEPARHTVSV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Arc Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Arc (Activity-Regulated Cytoskeleton-Associated Protein (Arc))
- Background
-
Arc is required for consolidation of synaptic plasticity as well as formation of long-term memory. Regulates endocytosis of AMPA receptors in response to synaptic activity. Required for homeostatic synaptic scaling of AMPA receptors.
Alias Symbols: Arc3.1, C86064, arg3.1
Protein Size: 396 - Molecular Weight
- 45 kDa
- Gene ID
- 11838
- NCBI Accession
- NM_001106278, NP_001099748
- UniProt
- B5DF02
-